Skip to content

2030 at other companies

CHE
ChemedCHE
Cardinal Health logo
Cardinal HealthCAH
Humana logo
HumanaHUM

Other financials

Income statement

See full
Revenue$1.2B+6.0%
Gross profit$340.5M-2.3%
Operating income$57.8M+21.8%
Net income$29.1M+21.8%
EPS (diluted)$6.62+21.5%

Balance sheet

See full
Cash & equivalents$234.0M+13.1%
Total debt$1.4B-6.4%
Total equity$4.7B+10.2%
Total assets$8.2B+7.4%

Cash flow

See full
Operating cash flow$67.7M+47.2%
CapEx$19.2M+23.8%
Free cash flow$48.6M+59.0%

Valuation

See full
Market cap$4.93B+9.7%
Enterprise value$6.05B+5.3%
P/E16.6×+9.4×
P/S+0.1×

Profitability

See full
Gross margin29.7%-2.6pp
Operating margin4.9%+0.2pp
Net margin6%-7.0pp
FCF margin5.9%-1.9pp

Returns & leverage

See full
Return on equity6.6%-8.4pp
Debt / equity0.3×-0.1×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Graham Holdings in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.

The official record: Graham Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Graham Holdings's 2030.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Graham Holdings's 2030?
Graham Holdings (GHC) reported 2030 of $5M in Q1 2026.
How has Graham Holdings's 2030 changed year-over-year?
Graham Holdings's 2030 increased by 400.0% year-over-year, from $1M to $5M.